Month: May 2026

$5.5 Million Settlement Secured in Pharmaceutical Litigation

Scott+Scott, along with co-counsel, have obtained preliminary approval of a $5.5 million settlement against defendants Teva Pharmaceuticals USA, Inc., Granules Pharmaceuticals, Inc., and Heritage Pharmaceuticals, Inc in a long running litigation pending in the United States District Court, District of New Jersey.  The plaintiffs alleged that the defendants marketed and sold generic metformin that were contaminated with N-nitrosodimethylamine (“NDMA”), and that this metformin was not approved by the U.S. Food and Drug Administration and could not be sold to the public.